Skip to search formSkip to main contentSkip to account menu

Brivaracetam

Known as: (2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide, 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-, 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objectives To assess state and trait anger, adjusted by epilepsy type, seizure control, anxiety-depression status and quality of… 
Review
2017
Review
2017
Commentary Brivaracetam (BRV) is the latest antiepileptic drug to reach the marketplace, and many clinicians are contemplating… 
2017
2017
Objective: To determine the speed of brain entrance of the antiepileptic drugs (AEDs) brivaracetam (BRV) and levetiracetam (LEV… 
Review
2017
Review
2017
The newest antiepileptic drug (AED) brivaracetam (Briviac, UCB Pharma) (BRV) was approved in the Russian Federation in 2017 as an… 
2016
2016
The invention discloses a method for preparing brivaracetam. The method for preparing brivaracetam comprises the following step… 
2016
2016
Emtricitabine/rilpivirine/tenofovir alafenamide (Odefsey) for combination HIV-1 therapy; dapsone gel, 7.5% (Aczone) for acne… 
Review
2015
Review
2015
This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and… 
2015
2015
The invention provides a method for synthesizing brivaracetam. Raw materials used in the method are available and inexpensive, a… 
2011
2011
The present invention relates brivaracetam or sustained release pharmaceutical composition comprising a pharmaceutically…